Anders Gersel Pedersen

Anders Gersel Pedersen

Chairman at AELIS FARMA

Net worth: 3 M $ as of 29/04/2024

73 year
Health Technology
Consumer Services
Health Services

Profile

Dr. Anders Gersel Pedersen is a Chairman at Aelis Farma SA, an Independent Director at Hansa Biopharma AB, a Chairman at Fonden Lundbeck International Neuroscience Foundation, a Chief Executive Officer at Gerselconsult ApS, a Deputy Chairman at Bavarian Nordic GmbH, a Member at American Society of Clinical Oncology, Inc., a Member at Danish Society of Internal Medicine, a Member at Danish Society of Medical Oncology, a Member at European Society for Medical Oncology and a Member at International Association for the Study of Lung Cancer.
He is on the Board of Directors at Avillion LLP, Hansa Biopharma AB, Bavarian Nordic A/S, Genmab A/S, Bavarian Nordic GmbH, Bond 2 Development 2 Gp Ltd., Bond Avillion 2 Development LP and Lundbeck Cognitive Therapeutics A/S.
Dr. Pedersen was previously employed as an Independent Director by ALK-Abello A/S, an Executive Vice President-Research & Development by H.
Lundbeck A/S, and an Executive Director by Eli Lilly & Co. He also served on the board at Chr.
Hansen A/S, Topotarget A/S and TopoTarget UK Ltd.
He received his undergraduate degree from Copenhagen Business School and a doctorate degree from the University of Copenhagen.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
13/02/2024 9,292 ( 0.01% ) 3 M $ 29/04/2024
30/12/2022 16,959 ( 0.02% ) 373 201 $ 29/04/2024
30/12/2022 2,500 ( 0.00% ) 6 592 $ 29/04/2024

Anders Gersel Pedersen active positions

CompaniesPositionStart
BAVARIAN NORDIC A/S Director/Board Member 26/04/2010
GENMAB A/S Director/Board Member 31/10/2003
HANSA BIOPHARMA AB Director/Board Member 28/05/2018
AELIS FARMA Chairman 31/12/2019
Bond Avillion 2 Development LP Director/Board Member -
Bond 2 Development 2 Gp Ltd. Director/Board Member -
Director/Board Member 04/09/2019
Director/Board Member 31/12/2013
Lundbeck Cognitive Therapeutics A/S Director/Board Member -
░░░░░░ ░░░░░░░░ ░░░░░░░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░ -
All active positions of Anders Gersel Pedersen

Former positions of Anders Gersel Pedersen

CompaniesPositionEnd
░░ ░░░░░░░░ ░░░ ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░░ ░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░░░ ░░░ ░░░░░░░░░░░░░░ ░░░░░░ -
░░░░ ░░░░░░ ░░░ ░░░░░░░░░░░░░░ ░░░░░░ -
░░░ ░░░░░ ░░░ ░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
See the detail of Anders Gersel Pedersen's experience

Training of Anders Gersel Pedersen

University of Copenhagen Doctorate Degree
Copenhagen Business School Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Anders Gersel Pedersen's experience

Connections

100 +

1st degree connections

24

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies7
H. LUNDBECK A/S

Health Technology

BAVARIAN NORDIC A/S

Health Technology

ALK-ABELLÓ A/S

Health Technology

ELI LILLY AND COMPANY

Health Technology

GENMAB A/S

Health Technology

HANSA BIOPHARMA AB

Health Technology

AELIS FARMA

Health Technology

Private companies15

Retail Trade

Health Services

Health Services

Health Technology

International Association for the Study of Lung Cancer

Danish Society of Medical Oncology

Danish Society of Internal Medicine

Health Technology

Fonden Lundbeck International Neuroscience Foundation

Miscellaneous

Lundbeck Cognitive Therapeutics A/S

Health Technology

Health Technology

Bond 2 Development 2 Gp Ltd.

Bond Avillion 2 Development LP

Gerselconsult ApS

See company connections
  1. Stock Market
  2. Insiders
  3. Anders Gersel Pedersen